BMSi

1. Osteostrong increases BMSi in humans (osteopenia or osteoporosis) (+2.9%, p = 0.026).

   “There was a significant increase in BMSi by 2.9% in the OS group (from 73.9 ± 9.5 to 76 ± 9.4, p = 0.026)”

   Human trialosteopenia or osteoporosistibiaonce-weekly (20 min)9 monthsfemalesn = 194

   The effect of OsteoStrong compared to dynamic multicomponent exercise on bone strength in older women: the BONEMORE non-inferiority randomized controlled trial

   Archives of osteoporosis·Feb 26, 2026

More on Osteostrong

1. BMSi predicts wrist fracture susceptibility in humans (AUC 0.77 [95% CI 0.63 to 0.90], p = 0.003).

   “Both BMSi (AUC 0.77 [95% CI 0.63 to 0.90]; p = 0.003) and TH-BMD (AUC 0.78 [95% CI 0.64 to 0.90]; p = 0.002) classified wrist fracture susceptibility”

   Humanswristn = 67

   Impact Microindentation Evaluates Bone Strength, Bone Quality, and Fracture Susceptibility Across Skeletal Sites: A Cadaver Study

   Clinical orthopaedics and related research·Jul 2, 2026

1. BMSi predicts hip fracture susceptibility in humans (AUC 0.75 [95% CI 0.63 to 0.88], p < 0.001).

   “BMSi discriminated hip fracture susceptibility with moderate accuracy (area under the curve [AUC] 0.75 [95% CI 0.63 to 0.88]; p < 0.001)”

   Humanshipn = 67

   Impact Microindentation Evaluates Bone Strength, Bone Quality, and Fracture Susceptibility Across Skeletal Sites: A Cadaver Study

   Clinical orthopaedics and related research·Jul 2, 2026

1. BMSi is associated with bone strength in humans (r = 0.62 [95% CI 0.49 to 0.72], p < 0.001).

   “Higher BMSi values were positively associated with higher bone strength, showing moderate association at the femur (r = 0.62 [95% confidence interval (CI) 0.49 to 0.72]; p < 0.001)”

   Humansfemurn = 67

   Impact Microindentation Evaluates Bone Strength, Bone Quality, and Fracture Susceptibility Across Skeletal Sites: A Cadaver Study

   Clinical orthopaedics and related research·Jul 2, 2026